produced by many strains of Aspergillus fungi
Vibrant Mycotoxin Test Results Explained
The Vibrant Mycotoxins test is a urine-based assay for 31 of the most common mycotoxins produced by molds to which humans are exposed.
Individuals most at risk for mycotoxin exposure include those who live or work in older buildings, those who have known exposure to water-damaged buildings, and those with impaired immune responses or higher levels of oxidative stress.
Mycotoxins complicate human health in a number of ways and their presence in the human body can lead to a number of serious health concerns, including autoimmune disease and cancer.
There may be higher incidence of autoimmune or neurological symptoms in your patients with mycotoxin toxicity. Consider screening for Hashimoto’s thyroiditis, connective tissue disorders, celiac disease, and neurological autoimmunity along with mycotoxin testing.
Treatment of mycotoxin exposure should include a holistic approach to eradicate the mold from the individual, thorough and professional removal of mold from environmental sources, and continued testing to monitor reductions in mycotoxin levels post-intervention.
Due to the common co-occurrence of Lyme and mycotoxin exposure from depressed immunity in affected individuals, as well as symptom overlap between tickborne diseases and mycotoxins, consider running the Vibrant Tickborne Diseases panel along with the Vibrant Mycotoxins test.
Biomarkers in this category
24 biomarkers · optimal ranges shown
a mycotoxin produced by several Aspergillus spp
related to mold species Aspergillus
one of the highest volume of chemicals produced worldwide.
a mycotoxin produced by Aspergillus
produced by several species of Fusarium
found to co-occur with many other mycotoxins in grains and grain-based products
a metabolite of Citrinin
metabolite of the flame retardant TPHP
mycotoxin growing on moldy corn (maize) grain
Fumonisin B3 (FB3), a less commonly studied but significant mycotoxin, is an important marker in Total Tox Burden panels, reflecting potential exposure to toxins produced by Fusarium species, predominantly found in maize and its by-products. Structurally, FB3 is similar to other fumonisins like B1 and B2, but it is often present at lower concentrations in contaminated foods. Its inclusion in tox burden assessments is crucial due to its potential health implications. Although FB3's toxicity is generally considered to be lower than that of fumonisin B1, it still poses health risks, particularly hepatotoxic and nephrotoxic effects, and it may play a role in esophageal cancer and neural tube defects. The presence of FB3 in a Total Tox Burden panel indicates exposure to Fusarium toxins and necessitates the examination of dietary intake, especially corn-based products, which are the primary source. Preventive strategies focus on agricultural practices to limit fungal contamination and post-harvest interventions to reduce mycotoxin levels. Current research into FB3's biological effects and its interactions with other mycotoxins is essential for understanding its full impact on human health and for the development of more effective detection and detoxification methods. This is particularly relevant as global climate change may alter the distribution and prevalence of Fusarium species, potentially leading to increased exposure to fumonisins, including FB3.
produced by the mold genus Aspergillus
the world's most widely produced herbicide
another trichothecene produced by Stachybotrys chartarum
a metabolite of mono(2-ethylhexyl) phthalate (MEHP)
a metabolite of DEP (diethyl phthalate)
produced by the mold genus Fusarium
a toxic chemical contaminant produced by several species of mold.
produced mainly by Stachybotrys
a trichothecene produced by Stachybotrys chartarum.